Cannabis

298 cannabis stocks trade on N.A. stock exchanges and are down 25.9% YTD. Lorimer Wilson from MunKNEE.com highlights the performance of the 12 “momentum” stocks within the Non-penny Pot Stock Index that are all up this year. [more]

Since Canada approved the sale of cannabis derivatives late last year, the high-margin cannabis beverage market quickly grew with the introduction of new products and brands, and an increase in M&A, financings, and other deals. [more]

Recently, the psychedelic market garnered the attention of investors as the industry was catalyzed by IPOs from MindMed Medicine and Champignon Brands with both companies quickly reaching market caps of over $100M due to significant demand in this new space. [more]

Canopy Growth, the largest cannabis company in the world based on market cap, reported full year earnings for F2020, with a 73% increase in revenue year-over-year, however, its bottom line reached over C$1 billion in losses due to restructuring initiatives, costing upwards of C$700 million. [more]

As the coronavirus negatively affects the business world and companies cut or pull guidance, here are three companies, backed by recently released financial results, which have reaffirmed growth guidance for 2020 – Sangoma, Trulieve and Xebec. [more]

Revenue growth expected from cultivation and retail operations in California, Illinois and Pennsylvania, and from recent Origin House acquisition. [more]

Other major events and reports related to the cannabis industry include: Cannabis Treatments for COVID-19; Canopy Growth loses two executives; Green Thumb Industries triples revenue; Tilray hopes to be profitable by year-end; United Cannabis files for bankruptcy. [more]

State-of-the-art cultivation and manufacturing facility expands capacity by 66,000 sq. ft to a total of 88,000 sq. ft of indoor and greenhouse space. [more]